While the relatively low power of the polygenic and familial risk factors mean that convergence of effects on lipid metabolism and AD across a subset of genetic loci cannot be ruled out, it is clear that polygenic and familial risk should be separated out from APOE effects in AD research into lipid metabolism to avoid conflating their effects. Here, APOE is linked to Alzheimer disease.